We analyzed the CSF2RB promoter methylation level in breast invasive carcinoma samples from TCGA and among the major subclasses based on the patient’s race and the pathological stage of breast invasive carcinoma per TCGA sample. The gene discussed is CSF2RB; the disease is invasive breast carcinoma.